• Optomed established Option Plan 2026A on September 25, 2026, offering 613,130 stock options to its CEO and certain key employees.
• Each option entitles holders to one share at a subscription price of EUR 1.52.
• The subscription period runs from September 30, 2029, to September 30, 2032.
• Option Plans 2024A and 2025A were terminated; participants must waive existing options under series 2022A, 2024A or 2025A.
• Total outstanding stock options decreased by 119,370 following the new plan’s establishment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Optomed plc published the original content used to generate this news brief via Cision (Ref. ID: 20261106:BIT:5635:0) on November 06, 2026, and is solely responsible for the information contained therein.